{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:35:10Z","timestamp":1787578510201,"version":"build-2736575974"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL088256"],"award-info":[{"award-number":["R01HL088256"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["P01HL152958"],"award-info":[{"award-number":["P01HL152958"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR070837"],"award-info":[{"award-number":["R01AR070837"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Chem Biol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41589-026-02181-6","type":"journal-article","created":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T09:02:56Z","timestamp":1775466176000},"page":"1514-1527","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Munc13-4\u2013STX7 inhibitors impair endosomal TLR activation and systemic inflammation"],"prefix":"10.1038","volume":"22","author":[{"given":"Jennifer L.","family":"Johnson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7550-253X","authenticated-orcid":false,"given":"Elsa","family":"Meneses-Salas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binchu","family":"Shaji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhana","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6319-8331","authenticated-orcid":false,"given":"Evripidis","family":"Gavathiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosana","family":"Gonzalez-Quintial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hal M.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristi L.","family":"Marquardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8280-8887","authenticated-orcid":false,"given":"John","family":"Teijaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine C.","family":"Hedrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3159-8469","authenticated-orcid":false,"given":"Roberto","family":"Baccala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9612-4782","authenticated-orcid":false,"given":"Hugh","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1873-0277","authenticated-orcid":false,"given":"Sergio D.","family":"Catz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"2181_CR1","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nri2671","volume":"9","author":"PI Bird","year":"2009","unstructured":"Bird, P. I., Trapani, J. A. & Villadangos, J. A. Endolysosomal proteases and their inhibitors in immunity. Nat. Rev. Immunol. 9, 871\u2013882 (2009).","journal-title":"Nat. Rev. Immunol."},{"key":"2181_CR2","doi-asserted-by":"publisher","first-page":"6573","DOI":"10.4049\/jimmunol.177.10.6573","volume":"177","author":"JA Deane","year":"2006","unstructured":"Deane, J. A. & Bolland, S. Nucleic acid-sensing TLRs as modifiers of autoimmunity. J. Immunol. 177, 6573\u20136578 (2006).","journal-title":"J. Immunol."},{"key":"2181_CR3","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/j.1600-065X.2007.00572.x","volume":"220","author":"AM Krieg","year":"2007","unstructured":"Krieg, A. M. & Vollmer, J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol. Rev. 220, 251\u2013269 (2007).","journal-title":"Immunol. Rev."},{"key":"2181_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nm1590","volume":"13","author":"R Baccala","year":"2007","unstructured":"Baccala, R., Hoebe, K., Kono, D. H., Beutler, B. & Theofilopoulos, A. N. TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity. Nat. Med. 13, 543\u2013551 (2007).","journal-title":"Nat. Med."},{"key":"2181_CR5","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.tcb.2013.12.002","volume":"24","author":"BL Lee","year":"2014","unstructured":"Lee, B. L. & Barton, G. M. Trafficking of endosomal Toll-like receptors. Trends Cell Biol. 24, 360\u2013369 (2014).","journal-title":"Trends Cell Biol."},{"key":"2181_CR6","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1016\/j.febslet.2011.04.028","volume":"585","author":"KC Santegoets","year":"2011","unstructured":"Santegoets, K. C., van Bon, L., van den Berg, W. B., Wenink, M. H. & Radstake, T. R. Toll-like receptors in rheumatic diseases: are we paying a high price for our defense against bugs? FEBS Lett. 585, 3660\u20133666 (2011).","journal-title":"FEBS Lett."},{"key":"2181_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/416603a","volume":"416","author":"EA Leadbetter","year":"2002","unstructured":"Leadbetter, E. A. et al. Chromatin\u2013IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603\u2013607 (2002).","journal-title":"Nature"},{"key":"2181_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/nrd3203","volume":"9","author":"EJ Hennessy","year":"2010","unstructured":"Hennessy, E. J., Parker, A. E. & O\u2019Neill, L. A. Targeting Toll-like receptors: emerging therapeutics? Nat. Rev. Drug Discov. 9, 293\u2013307 (2010).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2181_CR9","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nature09102","volume":"465","author":"C Guiducci","year":"2010","unstructured":"Guiducci, C. et al. TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus. Nature 465, 937\u2013941 (2010).","journal-title":"Nature"},{"key":"2181_CR10","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1172\/JCI43157","volume":"121","author":"EM Behrens","year":"2011","unstructured":"Behrens, E. M. et al. Repeated TLR9 stimulation results in macrophage activation syndrome-like disease in mice. J. Clin. Invest. 121, 2264\u20132277 (2011).","journal-title":"J. Clin. Invest."},{"key":"2181_CR11","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nrrheum.2011.68","volume":"7","author":"ED Mellins","year":"2011","unstructured":"Mellins, E. D., Macaubas, C. & Grom, A. A. Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions. Nat. Rev. Rheumatol. 7, 416\u2013426 (2011).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2181_CR12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1196\/annals.1447.004","volume":"1150","author":"A Nair","year":"2008","unstructured":"Nair, A., Wolter, T. R., Meyers, A. J. & Zipris, D. Innate immune pathways in virus-induced autoimmune diabetes. Ann. N. Y. Acad. Sci. 1150, 139\u2013142 (2008).","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"2181_CR13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/hep.23365","volume":"51","author":"ZM Bamboat","year":"2010","unstructured":"Bamboat, Z. M. et al. Toll-like receptor 9 inhibition confers protection from liver ischemia-reperfusion injury. Hepatology 51, 621\u2013632 (2010).","journal-title":"Hepatology"},{"key":"2181_CR14","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1038\/nature07405","volume":"456","author":"SE Ewald","year":"2008","unstructured":"Ewald, S. E. et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456, 658\u2013662 (2008).","journal-title":"Nature"},{"key":"2181_CR15","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1038\/emboj.2011.441","volume":"31","author":"Y Li","year":"2012","unstructured":"Li, Y., Berke, I. C. & Modis, Y. DNA binding to proteolytically activated TLR9 is sequence-independent and enhanced by DNA curvature. EMBO J. 31, 919\u2013931 (2012).","journal-title":"EMBO J."},{"key":"2181_CR16","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1091\/mbc.e15-05-0283","volume":"27","author":"J He","year":"2016","unstructured":"He, J. et al. Munc13-4 interacts with syntaxin 7 and regulates late endosomal maturation, endosomal signaling, and TLR9-initiated cellular responses. Mol. Biol. Cell 27, 572\u2013587 (2016).","journal-title":"Mol. Biol. Cell"},{"key":"2181_CR17","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0092-8674(03)00855-9","volume":"115","author":"J Feldmann","year":"2003","unstructured":"Feldmann, J. et al. Munc13-4 is essential for cytolytic granules fusion and is mutated in a form of familial hemophagocytic lymphohistiocytosis (FHL3). Cell 115, 461\u2013473 (2003).","journal-title":"Cell"},{"key":"2181_CR18","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1111\/j.1600-0854.2008.00838.x","volume":"9","author":"AA Brzezinska","year":"2008","unstructured":"Brzezinska, A. A. et al. The Rab27a effectors JFC1\/Slp1 and Munc13-4 regulate exocytosis of neutrophil granules. Traffic 9, 2151\u20132164 (2008).","journal-title":"Traffic"},{"key":"2181_CR19","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1074\/jbc.M110.184762","volume":"286","author":"JL Johnson","year":"2010","unstructured":"Johnson, J. L., Hong, H., Monfregola, J., Kiosses, W. B. & Catz, S. D. MUNC13-4 restricts motility of RAB27A-expressing vesicles to facilitate lipopolysaccharide-induced priming of exocytosis in neutrophils. J. Biol. Chem. 286, 5647\u20135656 (2010).","journal-title":"J. Biol. Chem."},{"key":"2181_CR20","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1182\/blood-2011-02-339523","volume":"118","author":"ED Elstak","year":"2011","unstructured":"Elstak, E. D. et al. The Munc13-4\u2013Rab27 complex is specifically required for tethering secretory lysosomes at the plasma membrane. Blood 118, 1570\u20131578 (2011).","journal-title":"Blood"},{"key":"2181_CR21","doi-asserted-by":"publisher","first-page":"3423","DOI":"10.1074\/jbc.M115.705871","volume":"291","author":"JL Johnson","year":"2015","unstructured":"Johnson, J. L. et al. Munc13-4 is a Rab11-binding protein that regulates Rab11-positive vesicle trafficking and docking at the plasma membrane. J. Biol. Chem. 291, 3423\u20133438 (2015).","journal-title":"J. Biol. Chem."},{"key":"2181_CR22","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1083\/jcb.201109132","volume":"197","author":"KL Boswell","year":"2012","unstructured":"Boswell, K. L. et al. Munc13-4 reconstitutes calcium-dependent SNARE-mediated membrane fusion. J. Cell Biol. 197, 301\u2013312 (2012).","journal-title":"J. Cell Biol."},{"key":"2181_CR23","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1042\/bj3490247","volume":"349","author":"H Koch","year":"2000","unstructured":"Koch, H., Hofmann, K. & Brose, N. Definition of Munc13-homology-domains and characterization of a novel ubiquitously expressed Munc13 isoform. Biochem.J. 349, 247\u2013253 (2000).","journal-title":"Biochem.J."},{"key":"2181_CR24","doi-asserted-by":"publisher","first-page":"3022","DOI":"10.1016\/j.cell.2021.04.011","volume":"184","author":"EL Huttlin","year":"2021","unstructured":"Huttlin, E. L. et al. Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. Cell 184, 3022\u20133040 (2021).","journal-title":"Cell"},{"key":"2181_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1091\/mbc.e04-10-0923","volume":"16","author":"M Neeft","year":"2005","unstructured":"Neeft, M. et al. Munc13-4 is an effector of Rab27a and controls secretion of lysosomes in hematopoietic cells. Mol. Biol. Cell 16, 731\u2013741 (2005).","journal-title":"Mol. Biol. Cell"},{"key":"2181_CR26","doi-asserted-by":"publisher","first-page":"3397","DOI":"10.4049\/jimmunol.179.6.3397","volume":"179","author":"LN Arneson","year":"2007","unstructured":"Arneson, L. N. et al. Cutting edge: syntaxin 11 regulates lymphocyte-mediated secretion and cytotoxicity. J. Immunol. 179, 3397\u20133401 (2007).","journal-title":"J. Immunol."},{"key":"2181_CR27","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/76024","volume":"25","author":"G Menasche","year":"2000","unstructured":"Menasche, G. et al. Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. Nat. Genet. 25, 173\u2013176 (2000).","journal-title":"Nat. Genet."},{"key":"2181_CR28","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1093\/hmg\/ddi076","volume":"14","author":"U zur Stadt","year":"2005","unstructured":"zur Stadt, U. et al. Linkage of familial hemophagocytic lymphohistiocytosis (FHL) type-4 to chromosome 6q24 and identification of mutations in syntaxin 11. Hum. Mol. Genet. 14, 827\u2013834 (2005).","journal-title":"Hum. Mol. Genet."},{"key":"2181_CR29","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1002\/art.23734","volume":"58","author":"K Zhang","year":"2008","unstructured":"Zhang, K. et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with Munc13-4 polymorphisms. Arthritis Rheum. 58, 2892\u20132896 (2008).","journal-title":"Arthritis Rheum."},{"key":"2181_CR30","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3899\/jrheum.100655","volume":"38","author":"M Yanagimachi","year":"2011","unstructured":"Yanagimachi, M. et al. Association of IRF5 polymorphisms with susceptibility to macrophage activation syndrome in patients with juvenile idiopathic arthritis. J. Rheumatol. 38, 769\u2013774 (2011).","journal-title":"J. Rheumatol."},{"key":"2181_CR31","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1084\/jem.20091776","volume":"207","author":"K Gotoh","year":"2010","unstructured":"Gotoh, K. et al. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation. J. Exp. Med. 207, 721\u2013730 (2010).","journal-title":"J. Exp. Med."},{"key":"2181_CR32","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1128\/IAI.05043-11","volume":"79","author":"JL Johnson","year":"2011","unstructured":"Johnson, J. L., Hong, H., Monfregola, J. & Catz, S. D. Increased survival and reduced neutrophil infiltration of the liver in Rab27a- but not Munc13-4-deficient mice in lipopolysaccharide-induced systemic inflammation. Infect. Immun. 79, 3607\u20133618 (2011).","journal-title":"Infect. Immun."},{"key":"2181_CR33","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ab.2006.05.017","volume":"356","author":"SM Riddle","year":"2006","unstructured":"Riddle, S. M., Vedvik, K. L., Hanson, G. T. & Vogel, K. W. Time-resolved fluorescence resonance energy transfer kinase assays using physiological protein substrates: applications of terbium-fluorescein and terbium-green fluorescent protein fluorescence resonance energy transfer pairs. Anal. Biochem. 356, 108\u2013116 (2006).","journal-title":"Anal. Biochem."},{"key":"2181_CR34","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1089\/adt.2008.152","volume":"6","author":"LA Hu","year":"2008","unstructured":"Hu, L. A., Zhou, T., Hamman, B. D. & Liu, Q. A homogeneous G protein-coupled receptor ligand binding assay based on time-resolved fluorescence resonance energy transfer. Assay Drug Dev. Technol. 6, 543\u2013550 (2008).","journal-title":"Assay Drug Dev. Technol."},{"key":"2181_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114598","volume":"43","author":"J Yu","year":"2024","unstructured":"Yu, J. et al. Defective endomembrane dynamics in Rab27a deficiency impairs nucleic acid sensing and cytokine secretion in immune cells. Cell Rep. 43, 114598 (2024).","journal-title":"Cell Rep."},{"key":"2181_CR36","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1532\/IJH97.04116","volume":"81","author":"T Maeda","year":"2005","unstructured":"Maeda, T. et al. A novel plasmacytoid dendritic cell line, CAL-1, established from a patient with blastic natural killer cell lymphoma. Int. J. Hematol. 81, 148\u2013154 (2005).","journal-title":"Int. J. Hematol."},{"key":"2181_CR37","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1080\/15548627.2019.1596475","volume":"15","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Cross-regulation of defective endolysosome trafficking and enhanced autophagy through TFEB in UNC13D deficiency. Autophagy 15, 1738\u20131756 (2019).","journal-title":"Autophagy"},{"key":"2181_CR38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/978-1-0716-1044-2_13","volume":"2233","author":"JL Johnson","year":"2021","unstructured":"Johnson, J. L., Pestonjamasp, K., Kiosses, W. B. & Catz, S. D. Super-resolution microscopy and particle-tracking approaches for the study of vesicular trafficking in primary neutrophils. Methods Mol. Biol. 2233, 193\u2013202 (2021).","journal-title":"Methods Mol. Biol."},{"key":"2181_CR39","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.1016\/j.cub.2016.06.046","volume":"26","author":"NA Bright","year":"2016","unstructured":"Bright, N. A., Davis, L. J. & Luzio, J. P. Endolysosomes are the principal intracellular sites of acid hydrolase activity. Curr. Biol. 26, 2233\u20132245 (2016).","journal-title":"Curr. Biol."},{"key":"2181_CR40","doi-asserted-by":"publisher","first-page":"25965","DOI":"10.1074\/jbc.M116.741884","volume":"291","author":"JL Johnson","year":"2016","unstructured":"Johnson, J. L. et al. Identification of neutrophil exocytosis inhibitors (Nexinhibs), small molecule inhibitors of neutrophil exocytosis and inflammation: druggability of the small GTPase Rab27a. J. Biol. Chem. 291, 25965\u201325982 (2016).","journal-title":"J. Biol. Chem."},{"key":"2181_CR41","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1080\/14756360701425014","volume":"22","author":"P Shah","year":"2007","unstructured":"Shah, P. & Westwell, A. D. The role of fluorine in medicinal chemistry. J. Enzyme Inhib. Med. Chem. 22, 527\u2013540 (2007).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"2181_CR42","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203118","volume":"13","author":"R Gonzalez-Quintial","year":"2018","unstructured":"Gonzalez-Quintial, R. et al. Lupus acceleration by a MAVS-activating RNA virus requires endosomal TLR signaling and host genetic predisposition. PLoS ONE 13, e0203118 (2018).","journal-title":"PLoS ONE"},{"key":"2181_CR43","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1189\/jlb.3AB0416-189RR","volume":"101","author":"M Ramadass","year":"2016","unstructured":"Ramadass, M., Johnson, J. L. & Catz, S. D. Rab27a regulates GM-CSF-dependent priming of neutrophil exocytosis. J. Leukoc. Biol. 101, 693\u2013702 (2016).","journal-title":"J. Leukoc. Biol."},{"key":"2181_CR44","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1398-9995.2006.01089.x","volume":"61","author":"MR Logan","year":"2006","unstructured":"Logan, M. R. et al. A critical role for vesicle-associated membrane protein-7 in exocytosis from human eosinophils and neutrophils. Allergy 61, 777\u2013784 (2006).","journal-title":"Allergy"},{"key":"2181_CR45","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1023\/A:1010903804063","volume":"25","author":"JE Smolen","year":"2001","unstructured":"Smolen, J. E., Hessler, R. J., Nauseef, W. M., Goedken, M. & Joe, Y. Identification and cloning of the SNARE proteins VAMP-2 and syntaxin-4 from HL-60 cells and human neutrophils. Inflammation 25, 255\u2013265 (2001).","journal-title":"Inflammation"},{"key":"2181_CR46","doi-asserted-by":"crossref","unstructured":"Hodgetts, K. J., Combs, K. J., Elder, A. M. & Harriman, G. C. The role of fluorine in the discovery and optimization of CNS agents. In Annual Reports in Medicinal Chemistry (ed. John E. Macor) (Academic Press, 2010).","DOI":"10.1016\/S0065-7743(10)45026-5"},{"key":"2181_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24021339","volume":"24","author":"SL Ford","year":"2023","unstructured":"Ford, S. L. et al. Toll-like receptor 9 induced dendritic cell activation promotes anti-myeloperoxidase autoimmunity and glomerulonephritis. Int. J. Mol. Sci. 24, 1339 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"2181_CR48","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1172\/JCI83885","volume":"126","author":"I Garcia-Martinez","year":"2016","unstructured":"Garcia-Martinez, I. et al. Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J. Clin. Invest. 126, 859\u2013864 (2016).","journal-title":"J. Clin. Invest."},{"key":"2181_CR49","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1136\/ard.2006.068676","volume":"66","author":"GS Alarcon","year":"2007","unstructured":"Alarcon, G. S. et al. Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L). Ann. Rheum. Dis. 66, 1168\u20131172 (2007).","journal-title":"Ann. Rheum. Dis."},{"key":"2181_CR50","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10787-015-0239-y","volume":"23","author":"KD Rainsford","year":"2015","unstructured":"Rainsford, K. D., Parke, A. L., Clifford-Rashotte, M. & Kean, W. F. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases. Inflammopharmacology 23, 231\u2013269 (2015).","journal-title":"Inflammopharmacology"},{"key":"2181_CR51","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1136\/ard.2010.143347","volume":"70","author":"P Tynjala","year":"2011","unstructured":"Tynjala, P. et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Ann. Rheum. Dis. 70, 1605\u20131612 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"2181_CR52","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1002\/acr.20133","volume":"62","author":"F Wolfe","year":"2010","unstructured":"Wolfe, F. & Marmor, M. F. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res. (Hoboken) 62, 775\u2013784 (2010).","journal-title":"Arthritis Care Res. (Hoboken)"},{"key":"2181_CR53","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.2008.101766","volume":"69","author":"G Ruiz-Irastorza","year":"2010","unstructured":"Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P. & Khamashta, M. A. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann. Rheum. Dis. 69, 20\u201328 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"2181_CR54","first-page":"808","volume":"26","author":"C Wang","year":"1999","unstructured":"Wang, C. et al. Discontinuation of antimalarial drugs in systemic lupus erythematosus. J. Rheumatol. 26, 808\u2013815 (1999).","journal-title":"J. Rheumatol."},{"key":"2181_CR55","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ncprheum0292","volume":"2","author":"D Kyburz","year":"2006","unstructured":"Kyburz, D., Brentano, F. & Gay, S. Mode of action of hydroxychloroquine in RA\u2014evidence of an inhibitory effect on toll-like receptor signaling. Nat. Clin. Pract. Rheumatol. 2, 458\u2013459 (2006).","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"2181_CR56","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1084\/jem.20062447","volume":"204","author":"K Crozat","year":"2007","unstructured":"Crozat, K. et al. Jinx, an MCMV susceptibility phenotype caused by disruption of Unc13d: a mouse model of type 3 familial hemophagocytic lymphohistiocytosis. J. Exp. Med. 204, 853\u2013863 (2007).","journal-title":"J. Exp. Med."},{"key":"2181_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1255533","volume":"14","author":"E Grebenciucova","year":"2023","unstructured":"Grebenciucova, E. & VanHaerents, S. Interleukin 6: at the interface of human health and disease. Front. Immunol. 14, 1255533 (2023).","journal-title":"Front. Immunol."},{"key":"2181_CR58","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","volume":"16","author":"EH Choy","year":"2020","unstructured":"Choy, E. H. et al. Translating IL-6 biology into effective treatments. Nat. Rev. Rheumatol. 16, 335\u2013345 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"2181_CR59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/s41577-021-00547-6","volume":"22","author":"EC Morris","year":"2022","unstructured":"Morris, E. C., Neelapu, S. S., Giavridis, T. & Sadelain, M. Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy. Nat. Rev. Immunol. 22, 85\u201396 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"2181_CR60","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44648-3","volume":"15","author":"S Yang","year":"2024","unstructured":"Yang, S. et al. Neutrophil activation and clonal CAR-T re-expansion underpinning cytokine release syndrome during ciltacabtagene autoleucel therapy in multiple myeloma. Nat. Commun. 15, 360 (2024).","journal-title":"Nat. Commun."},{"key":"2181_CR61","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2039432","volume":"11","author":"G Leclercq","year":"2022","unstructured":"Leclercq, G. et al. Dissecting the mechanism of cytokine release induced by T-cell engagers highlights the contribution of neutrophils. Oncoimmunology 11, 2039432 (2022).","journal-title":"Oncoimmunology"},{"key":"2181_CR62","first-page":"705","volume":"16","author":"S Si","year":"2020","unstructured":"Si, S. & Teachey, D. T. Spotlight on tocilizumab in the treatment of CAR-T-cell-induced cytokine release syndrome: clinical evidence to date. Ther. Clin. Risk Manag. 16, 705\u2013714 (2020).","journal-title":"Ther. Clin. Risk Manag."},{"key":"2181_CR63","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1634\/theoncologist.2018-0028","volume":"23","author":"RQ Le","year":"2018","unstructured":"Le, R. Q. et al. FDA approval summary: tocilizumab for treatment of chimeric antigen receptor T cell-induced severe or life-threatening cytokine release syndrome. Oncologist 23, 943\u2013947 (2018).","journal-title":"Oncologist"},{"key":"2181_CR64","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","volume":"117","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc. Natl Acad. Sci. USA 117, 10970\u201310975 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2181_CR65","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa2028700","volume":"384","author":"IO Rosas","year":"2021","unstructured":"Rosas, I. O. et al. Tocilizumab in hospitalized patients with severe COVID-19 pneumonia. N. Engl. J. Med. 384, 1503\u20131516 (2021).","journal-title":"N. Engl. J. Med."},{"key":"2181_CR66","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3390\/ph13100317","volume":"13","author":"B Rossi","year":"2020","unstructured":"Rossi, B. et al. Effect of tocilizumab in hospitalized patients with severe COVID-19 pneumonia: a case\u2013control cohort study. Pharmaceuticals (Basel) 13, 317 (2020).","journal-title":"Pharmaceuticals (Basel)"},{"key":"2181_CR67","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33230-y","volume":"13","author":"JL Johnson","year":"2022","unstructured":"Johnson, J. L. et al. Differential dysregulation of granule subsets in WASH-deficient neutrophil leukocytes resulting in inflammation. Nat. Commun. 13, 5529 (2022).","journal-title":"Nat. Commun."},{"key":"2181_CR68","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1073\/pnas.0400525101","volume":"101","author":"K Tabeta","year":"2004","unstructured":"Tabeta, K. et al. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl Acad. Sci. USA 101, 3516\u20133521 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2181_CR69","doi-asserted-by":"crossref","unstructured":"Welsh, R. M. & Seedhom, M. O. Lymphocytic choriomeningitis virus (LCMV): propagation, quantitation, and storage. Curr. Protoc. Microbiol. Chapter 15, Unit 15A.1 (2008).","DOI":"10.1002\/9780471729259.mc15a01s8"},{"key":"2181_CR70","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","volume":"33","author":"M Battegay","year":"1991","unstructured":"Battegay, M. et al. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates. J. Virol. Methods 33, 191\u2013198 (1991).","journal-title":"J. Virol. Methods"},{"key":"2181_CR71","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1083\/jcb.86.1.21","volume":"86","author":"MS Klempner","year":"1980","unstructured":"Klempner, M. S., Mikkelsen, R. B., Corfman, D. H. & Andr\u00e9-Schwartz, J. Neutrophil plasma membranes. I. High-yield purification of human neutrophil plasma membrane vesicles by nitrogen cavitation and differential centrifugation. J. Cell Biol. 86, 21\u201328 (1980).","journal-title":"J. Cell Biol."},{"key":"2181_CR72","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1091\/mbc.e11-12-1001","volume":"23","author":"JL Johnson","year":"2012","unstructured":"Johnson, J. L., Monfregola, J., Napolitano, G., Kiosses, W. B. & Catz, S. D. Vesicular trafficking through cortical actin during exocytosis is regulated by the Rab27a effector JFC1\/Slp1 and the RhoA-GTPase-activating protein Gem-interacting protein. Mol. Biol. Cell 23, 1902\u20131916 (2012).","journal-title":"Mol. Biol. Cell"},{"key":"2181_CR73","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1083\/jcb.89.1.141","volume":"89","author":"D Axelrod","year":"1981","unstructured":"Axelrod, D. Cell\u2013substrate contacts illuminated by total internal reflection fluorescence. J. Cell Biol. 89, 141\u2013145 (1981).","journal-title":"J. Cell Biol."}],"container-title":["Nature Chemical Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02181-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02181-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02181-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T13:12:24Z","timestamp":1787577144000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41589-026-02181-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":73,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2181"],"URL":"https:\/\/doi.org\/10.1038\/s41589-026-02181-6","relation":{},"ISSN":["1552-4450","1552-4469"],"issn-type":[{"value":"1552-4450","type":"print"},{"value":"1552-4469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"15 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}